| Indicators | Browse All

Teva Pharmaceutical Industries Limited (TEVA)

Healthcare | Drug Manufacturers - Specialty & Generic | Tel Aviv-Yafo, Israel | NYSE
32.18 USD -0.77 (-2.337%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 32.40 +0.22 (0.684%) ⇧ (July 13, 2026, 7:58 p.m. EDT)
Short-term:★★⯪☆☆Long-term:★★☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | July 11, 2026, 4:47 a.m. EDT

Teva presents a classic 'value trap' scenario where the narrative of a turnaround clashes with the reality of deteriorating fundamentals. While the stock has rallied significantly from its lows, the underlying business is struggling: revenue growth is stagnant at just 2.3%, and the company is facing a multi-year price decline where the last six of nine years saw negative returns. The balance sheet is fragile, with debt-to-equity exceeding 200%, which severely limits the ability to fund innovation without diluting shareholders. Despite the 'strong buy' analyst consensus and a target price implying a 25% upside, the lack of dividend support and the heavy debt load make this a risky proposition. The recent price action shows some resilience, trading above its 200-day average, but the statistical forecast offers no directional edge. Investors buying here are betting on a successful pivot to innovative drugs (like the Tourette's program) to offset generic patent cliffs, but until that revenue engine ignites, the high valuation and debt burden keep the long-term outlook mediocre.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.050787
AutoARIMA0.050788
MSTL0.065640
AutoTheta0.078409

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 42%
H-stat 4.71
Ljung-Box p 0.000
Jarque-Bera p 0.950
Excess Kurtosis -0.22
Attribute Value
Sector Healthcare
Ex Dividend Date 2017-11-26
Last Dividend Date 2017-11-26
Debt to Equity Ratio 205.6
Revenue per Share 15.093
Market Cap 37,471,260,672
Trailing P/E 24.56
Forward P/E 10.45
Beta 0.86
Profit Margins 9.02%
Website https://www.tevapharm.com

As of July 11, 2026, 4:47 a.m. EDT: Speculators are positioning for significant volatility rather than a clear directional breakout. Call Open Interest is heavily skewed out-of-the-money (OTM) at strikes like 37.0 and 42.0, suggesting bets on a sharp rally, while Put Open Interest clusters tightly around the money and slightly OTM (30.0–33.0), indicating a hedge against a drop to the 30s. The massive volume spike in deep OTM calls (42.0) versus negligible put volume at similar distances suggests asymmetric speculation on a potential 'comeback' scenario, yet the tight bid-ask spreads and low implied volatility relative to the volume suggest the market is pricing in a range-bound struggle rather than a confirmed trend.

Dividend Data

Dividend History
Date Dividend Yield %
2017-11-27 0.085000 0.580205
2017-08-25 0.085000 0.524368
2017-06-01 0.340000 1.172010
2017-02-28 0.340000 0.970874
2016-12-01 0.340000 0.929724
2016-08-18 0.340000 0.640905
2016-05-20 0.340000 0.654601
2016-02-25 0.340000 0.590483
2015-11-13 0.340000 0.586106
2015-08-18 0.340000 0.492539
2015-05-15 0.340000 0.564503
2015-02-17 0.340000 0.596491
2014-11-13 0.321000 0.561483
2014-08-19 0.353000 0.668687
2014-05-16 0.347000 0.696647
2014-02-20 0.345000 0.715768
2013-11-18 0.326000 0.853403
2013-08-16 0.322000 0.803794
2013-05-16 0.320000 0.800801
2013-02-19 0.310000 0.807712
2012-11-13 0.257000 0.650963
2012-08-13 0.249000 0.611944
2012-05-17 0.261000 0.672854
2012-02-23 0.267000 0.599596
2011-11-09 0.219000 0.539675
2011-08-04 0.235000 0.569559
2011-05-19 0.232000 0.461967
2011-02-10 0.215000 0.416667
2010-11-08 0.193000 0.379473
2010-08-02 0.181000 0.360414
2010-05-10 0.188000 0.317675
2010-02-19 0.186000 0.316650
2009-11-06 0.158000 0.303671
2009-08-03 0.154000 0.287421
2009-05-08 0.145000 0.329321
2009-02-23 0.148000 0.327000
2008-11-07 0.117000 0.274971
2008-08-01 0.130000 0.282057
2008-05-13 0.131000 0.292085
2008-02-15 0.125000 0.266468
2007-11-02 0.101000 0.229233
2007-08-10 0.092000 0.212324
2007-05-10 0.098000 0.254876
2007-02-16 0.094000 0.249271
2006-11-10 0.079000 0.249921
2006-08-11 0.078000 0.226021
2006-05-12 0.077000 0.205224
2006-03-06 0.072000 0.173703
2005-11-10 0.064000 0.161412
2005-08-11 0.067000 0.204082
2005-05-05 0.069000 0.218424
2005-02-17 0.069000 0.256315
2004-11-09 0.051000 0.200551
2004-08-09 0.050000 0.178380
2004-05-10 0.049000 0.157177
2004-02-20 0.050500 0.156057
2003-11-13 0.036500 0.127712
2003-08-08 0.037500 0.136190
2003-05-08 0.037000 0.157313
2003-02-24 0.034000 0.184732
2003-01-07 0.017500 0.089286
2002-11-07 0.022500 0.122150
2002-08-19 0.022750 0.132306
2002-05-20 0.022000 0.135031
2002-02-15 0.023250 0.156303
2001-11-16 0.016000 0.110326
2001-08-20 0.016000 0.089888
2001-05-17 0.016250 0.118332
2001-03-08 0.016500 0.113305
2000-11-16 0.013750 0.088000
2000-08-24 0.014000 0.086320
2000-05-19 0.013500 0.114135
1999-11-04 0.006625 0.105736
1999-08-18 0.006875 0.116402
1999-05-21 0.006875 0.108911
1999-03-08 0.007250 0.132006
1998-11-20 0.008125 0.150725
1998-11-16 0.008125 0.150289
1998-08-21 0.008125 0.166667
1998-05-21 0.008125 0.156391
1998-03-12 0.008500 0.161905
1997-11-20 0.008500 0.138599
1997-08-25 0.008500 0.123636
1997-05-23 0.007500 0.102128
1997-03-07 0.006500 0.081409
1996-11-20 0.006250 0.111111
1996-08-26 0.006250 0.137931
1996-05-23 0.006250 0.106101
1996-03-07 0.006250 0.118694
1995-11-20 0.006250 0.123267
1995-08-14 0.006250 0.122699
1995-05-17 0.008125 0.192950
1995-03-07 0.006500 0.188235
1994-11-15 0.006000 0.183732
1994-08-09 0.006250 0.180180
1994-03-08 0.005250 0.138843
1993-11-17 0.004625 0.122314
1993-08-17 0.004625 0.147264
1993-05-18 0.004375 0.150538
1993-04-07 0.002500 0.094395
1992-11-17 0.002500 0.123552
1992-08-18 0.003125 0.192308
1992-05-19 0.002625 0.168844
1992-03-03 0.002188 0.132732
1991-11-20 0.002188 0.205929
1991-08-21 0.002188 0.193148
1991-05-20 0.002500 0.273504
1991-03-05 0.002500 0.283186
1990-11-20 0.002313 0.314962
1990-08-17 0.002313 0.336436
1990-05-21 0.002188 0.325656
1990-03-08 0.002375 0.353488
1989-11-20 0.001938 0.275627
1989-08-16 0.001875 0.307692
1989-05-22 0.001938 0.354377
1989-03-09 0.002313 0.548267
1988-12-06 0.001875 0.452830
1988-09-08 0.002250 0.564705
1988-06-10 0.001750 0.471579
1988-04-12 0.001875 0.444444
1988-02-08 0.001875 0.600000
1987-10-23 0.001875 0.436363
1987-07-09 0.002375 0.361905
1987-06-22 0.001875 0.279070
1987-02-23 0.001875 0.342857
Additional Data
exDividendDate 2017-11-27
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 0.085
lastDividendDate 2017-11-27
dividendDate 2017-12-12

Info Dump

Attribute Value
52 Week Change 1.0066991
Address1 124 Dvora HaNevi’a St.
All Time High 72.31
All Time Low 0.0625
Ask 0.0
Ask Size 600
Average Analyst Rating 1.4 - Strong Buy
Average Daily Volume10 Day 5,048,440
Average Daily Volume3 Month 6,313,209
Average Volume 6,313,209
Average Volume10Days 5,048,440
Beta 0.859
Bid 0.0
Bid Size 900
Book Value 7.066
City Tel Aviv-Yafo
Compensation As Of Epoch Date 1,767,139,200
Country Israel
Crypto Tradeable 0
Currency USD
Current Price 32.18
Current Ratio 1.013
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 32.81
Day Low 32.14
Debt To Equity 205.6
Display Name Teva Pharmaceutical Industries
Dividend Date 1,513,036,800
Earnings Call Timestamp End 1,785,355,200
Earnings Call Timestamp Start 1,785,355,200
Earnings Growth 0.722
Earnings Quarterly Growth 0.724
Earnings Timestamp 1,785,328,200
Earnings Timestamp End 1,785,328,200
Earnings Timestamp Start 1,785,328,200
Ebitda 5,002,999,808
Ebitda Margins 0.28837
Enterprise To Ebitda 10.126
Enterprise To Revenue 2.92
Enterprise Value 50,659,258,368
Eps Current Year 2.2162
Eps Forward 3.07866
Eps Trailing Twelve Months 1.31
Esg Populated 0
Ex Dividend Date 1,511,740,800
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 34.262
Fifty Day Average Change -2.0820007
Fifty Day Average Change Percent -0.06076705
Fifty Two Week Change Percent 100.66991
Fifty Two Week High 37.35
Fifty Two Week High Change -5.169998
Fifty Two Week High Change Percent -0.1384203
Fifty Two Week Low 14.99
Fifty Two Week Low Change 17.19
Fifty Two Week Low Change Percent 1.1467645
Fifty Two Week Range 14.99 - 37.35
Financial Currency USD
First Trade Date Milliseconds 382,717,800,000
Five Year Avg Dividend Yield 2.95
Float Shares 1,083,278,056
Forward Eps 3.07866
Forward P E 10.4526
Free Cashflow 2,611,375,104
Full Exchange Name NYSE
Full Time Employees 31,173
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.52061003
Gross Profits 9,031,999,488
Has Pre Post Market Data 1
Held Percent Insiders 0.000040000003
Held Percent Institutions 0.6243
Implied Shares Outstanding 1,164,426,972
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,511,740,800
Last Dividend Value 0.085
Last Fiscal Year End 1,767,139,200
Last Split Date 1,088,640,000
Last Split Factor 2:1
Long Business Summary Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Long Name Teva Pharmaceutical Industries Limited
Market us_market
Market Cap 37,471,260,672
Market State PREPRE
Max Age 86,400
Message Board Id finmb_308047
Most Recent Quarter 1,774,915,200
Net Income To Common 1,564,999,936
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 38,770,139,949
Number Of Analyst Opinions 10
Open 32.52
Operating Cashflow 1,714,000,000
Operating Margins 0.19161
Payout Ratio 0.0
Peg Ratio 0.94
Phone 972 3 914 8213
Post Market Change 0.22000122
Post Market Change Percent 0.68365824
Post Market Price 32.4
Post Market Time 1,783,987,112
Previous Close 32.95
Price Eps Current Year 14.5203495
Price Hint 2
Price To Book 4.5542035
Price To Sales Trailing12 Months 2.1598513
Profit Margins 0.09021
Quick Ratio 0.527
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.41667
Region US
Regular Market Change -0.77
Regular Market Change Percent -2.33688
Regular Market Day High 32.81
Regular Market Day Low 32.14
Regular Market Day Range 32.14 - 32.81
Regular Market Open 32.52
Regular Market Previous Close 32.95
Regular Market Price 32.18
Regular Market Time 1,783,972,803
Regular Market Volume 3,163,841
Return On Assets 0.063829996
Return On Equity 0.21599
Revenue Growth 0.023
Revenue Per Share 15.093
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 1,164,426,972
Shares Percent Shares Out 0.0275
Shares Short 32,029,657
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 33,869,008
Short Name Teva Pharmaceutical Industries
Short Percent Of Float 0.0277
Short Ratio 5.16
Source Interval 15
Symbol TEVA
Target High Price 50.0
Target Low Price 33.0
Target Mean Price 40.9
Target Median Price 40.0
Total Cash 3,740,999,936
Total Cash Per Share 3.213
Total Debt 16,924,999,680
Total Revenue 17,348,999,168
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 1.31
Trailing P E 24.564886
Trailing Peg Ratio 0.9396
Triggerable 1
Two Hundred Day Average 29.7815
Two Hundred Day Average Change 2.3985004
Two Hundred Day Average Change Percent 0.08053659
Type Disp Equity
Volume 3,163,841
Website https://www.tevapharm.com
Zip 6,944,020